A Study to Evaluate the Efficacy and Safety of Enlicitide (MK-0616, Oral PCSK9 Inhibitor) Compared With Ezetimibe or Bempedoic Acid or Ezetimibe and Bempedoic Acid in Adults With Hypercholesterolemia (MK-0616-018/CORALreef AddOn)
Clinical trial NCT06450366 · COMPLETED
Trial details
- NCT number
- NCT06450366
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-08
- Primary completion
- 2025-02-14
- Enrollment
- 301
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.